PF-06726304

CAS No. 1616287-82-1

PF-06726304( PF06726304 )

Catalog No. M12356 CAS No. 1616287-82-1

PF-06726304 is a novel potent enhancer of zeste homolog 2 (EZH2) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 77 In Stock
2MG 44 In Stock
5MG 70 In Stock
10MG 121 In Stock
25MG 278 In Stock
50MG 494 In Stock
100MG 714 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-06726304
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-06726304 is a novel potent enhancer of zeste homolog 2 (EZH2) inhibitor.
  • Description
    PF-06726304 is a novel potent enhancer of zeste homolog 2 (EZH2) inhibitor with IC50 of <5 nM, Ki of 0.7/3.0 nM (Wt/Y641N); displays very potent EZH2 biochemical inhibition as well as good activity in the cell H3K27Me3 reduction (IC50=15 nM) and antiproliferation effect; also exhibits robust in vivo antitumor growth activity and dose-dependent de-repression of EZH2 target genes.
  • In Vitro
    PF-06726304 (Compound 31) inhibits H3K27me3 in Karpas-422 with an IC50 of 15 nM.PF-06726304 inhibits the proliferation of Karpas-422 cells that harbor wild-type EZH2 with an IC50 of 25 nM.
  • In Vivo
    PF-06726304 (200 and 300 mg/kg; BID for 20 days) inhibits tumor growth and induces robust modulation of downstream biomarkers in a subcutaneous Karpas-422 xenograft model. Animal Model:Female Scid beige mice (6-8 weeks old) with Karpas-422 xenograft model Dosage:200 and 300 mg/kg Administration:Given BID for 20 days Result:Inhibited tumor growth and induced robust modulation of downstream biomarkers in a subcutaneous Karpas-422 xenograft model.
  • Synonyms
    PF06726304
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    HMTase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1616287-82-1
  • Formula Weight
    446.328
  • Molecular Formula
    C22H21Cl2N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 15 mg/mL33.61 mM
  • SMILES
    O=C1N(CC2=C(C)C=C(C)NC2=O)CCC3=C1C(Cl)=C(C4=C(C)ON=C4C)C=C3Cl
  • Chemical Name
    5,8-dichloro-2-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-7-(3,5-dimethylisoxazol-4-yl)-3,4-dihydroisoquinolin-1(2H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kung PP, et al. J Med Chem. 2016 Sep 22;59(18):8306-25.
molnova catalog
related products
  • TM2-115

    A BIX-01294 derivative that inhibit malaria parasite histone methyltransferases, resulting in rapid and irreversible parasite death.

  • WDR5 WIN site inhibi...

    WDR5 WIN site inhibitor C3 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 1.3 nM.

  • LLY-507

    A potent, selective and cell-active inhibitor of SMYD2 (IC50<15 nM).